Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension

PHASE4TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 21, 2017

Primary Completion Date

June 20, 2019

Study Completion Date

May 19, 2020

Conditions
Pulmonary Hypertension
Interventions
DRUG

Iloprost and nitric oxide administration

Iloprost will be administered by the I-neb ultrasonic nebulizer (Respironics, Cedar Grove, New Jersey) with a disposable attachment that allows for administration to a supine patient at a concentration of 10 µg/ml with a 10 minute dose of 2.5 µg and then repeated to a cumulative dose of 5.0 µg if tolerated.

Trial Locations (1)

27710

Duke University Health System, Durham

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Actelion

INDUSTRY

lead

Duke University

OTHER